journal article·2017-05-19Open access

Fabrication and evaluation of nanoparticle-assembled BSA microparticles for enhanced liver delivery of glycyrrhetinic acid

Wenping Wang, Yaya Lei, Hong Sui, Wenping Zhang, Rongyue Zhu, Jun Feng, Hong Wang

Abstract

The aim of the present study was to prepare and evaluate microparticle formulation encapsulated with glycyrrhetinic acid (GA) based on bovine serum albumin (BSA). The drug-loaded nanoparticles were firstly formed by a simple desolvation method, and were further assembled into microparticles using zinc chloride and glutaraldehyde as crosslinkers. The obtained microparticles contained approximately 30% (w/w) drug and showed as spherical particles with a size of about 2 μm. Differential scanning calorimetry (DSC) and X-ray powder diffraction (XRPD) analysis indicated that GA lost its crystallinity during the nano/microencapsulation process. In vitro dissolution study demonstrated a typical sustained-release pattern for 24 h with a burst of 28.1% at the first 30 min, which fitted well by Higuchi model. After intravenous administration into mice, the microparticle formulation remained a higher drug level than the solution formulation in blood and liver for more than 18 h. These results suggested the potential benefit of using the prepared albumin microparticles as a promising vector for enhanced liver delivery of poorly water-soluble drug.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Pharmacological Effects of Natural Compounds · Phytochemistry and biological activity of medicinal plants · Ginseng Biological Effects and Applications

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

School of Pharmacy, Ningxia Medical University, Yinchuan, Ningxia, China;

Ningxia Engineering and Technology Research Center for Modernization of Hui Medicine, Yinchuan, Ningxia, China;

Key Lab of Hui Ethnic Medicine Modernization, Ministry of Education, Yinchuan, Ningxia, China;

Department of Pharmaceutics, General Hospital of Ningxia Medical University, Yinchuan, Ningxia, China

Funding

National Natural Science Foundation of China

References (30)

Show source-provided references
1. 10.1016/j.carbpol.2015.05.04210.1016/j.carbpol.2015.05.042 ↗
2. 10.1016/S0168-3659(99)00219-910.1016/S0168-3659(99)00219-9 ↗
3. 10.1016/S0168-3659(02)00211-010.1016/S0168-3659(02)00211-0 ↗
4. Ci Y · Int J Clin Exp Med · 2015 · 8 · 12404
5. 10.3109/1061186X.2010.50427210.3109/1061186X.2010.504272 ↗
6. 10.3109/02652048.2013.81472810.3109/02652048.2013.814728 ↗
7. 10.1016/j.jconrel.2011.07.03110.1016/j.jconrel.2011.07.031 ↗
8. Guo BH · Chin Trad Herb Drug · 2010 · 41 · 380
9. 10.3109/08982104.2011.62751510.3109/08982104.2011.627515 ↗
10. Han TF · Northwest Pharmaceut J · 2012 · 27 · 64
11. 10.1016/j.cherd.2013.11.02410.1016/j.cherd.2013.11.024 ↗
12. 10.1016/j.ejps.2004.02.00710.1016/j.ejps.2004.02.007 ↗
13. 10.1016/S0378-5173(03)00134-010.1016/S0378-5173(03)00134-0 ↗
14. 10.1208/s12249-011-9750-710.1208/s12249-011-9750-7 ↗
15. Liu HQ · Guangdong Chem Ind · 2005 · 8 · 37
16. 10.1016/j.ijpharm.2007.12.04710.1016/j.ijpharm.2007.12.047 ↗
17. Minamimura T · Int J Oncol · 2000 · 16 · 1153
18. 10.1016/S0168-1656(00)00242-X10.1016/S0168-1656(00)00242-X ↗
19. 10.1038/srep1137110.1038/srep11371 ↗
20. 10.1016/S0378-5173(01)00600-710.1016/S0378-5173(01)00600-7 ↗
21. 10.1007/s11051-013-2043-110.1007/s11051-013-2043-1 ↗
22. 10.1016/j.critrevonc.2014.06.00110.1016/j.critrevonc.2014.06.001 ↗
23. 10.1016/j.ijbiomac.2012.07.01410.1016/j.ijbiomac.2012.07.014 ↗
24. 10.3109/10717544.2013.87160010.3109/10717544.2013.871600 ↗
25. 10.1016/S0378-5173(99)00420-210.1016/S0378-5173(99)00420-2 ↗
26. 10.1016/j.biomaterials.2015.01.01110.1016/j.biomaterials.2015.01.011 ↗
27. 10.1021/la302758g10.1021/la302758g ↗
28. 10.1111/j.2042-7158.2012.01516.x10.1111/j.2042-7158.2012.01516.x ↗
29. 10.1016/j.ijbiomac.2012.05.00510.1016/j.ijbiomac.2012.05.005 ↗
30. Zhong DG · Mater Rev B · 2012 · 26 · 77